Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein

By Kappelle Paul JWH   Zwang Louwerens   Huisman Menno V   Banga Jan Dirk   Sluiter Wim J   Dallinga-Thie Geesje M   Dullaart Robin PF  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 743-751

Informa Healthcare

Access to resources Recommend Favorite

High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?

By  

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1494-1503

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond Low-Density Lipoprotein: Addressing the Atherogenic Lipid Triad in Type 2 Diabetes Mellitus and the Metabolic Syndrome

By Nesto Richard W.  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 6, 2005-01 ,pp. : 379-387

Adis International

Access to resources Recommend Favorite

Pharmacological Strategies to Reduce Cardiovascular Risk in Type 2 Diabetes Mellitus: An Update

By Marcel M.C. Hovens   Jouke T. Tamsma   Edith D. Beishuizen   Menno V. Huisman  

Drugs, Vol. 65, Iss. 4, 2005-01 ,pp. : 433-445

Adis International

Access to resources Recommend Favorite

Future anti-inflammatory metabolic and cardiovascular management of Type 2 diabetes mellitus

By Laight David W  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 11, 2003-11 ,pp. : 1683-1689

Informa Healthcare

Access to resources Recommend Favorite